Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Dopamine Transporter Ligand [18F]FECNT

NCT00083629 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00083629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00083629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Dopamine Transporter Ligand [18F]FECNT
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2004
Completion date
September 30, 2005
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy